The Journal of Neuroscience, February 4, 2009, 29(5):1350-1360; doi:10.1523/JNEUROSCI.3770-08.2009
Previous Article | Next Article 
Development/Plasticity/Repair
Regulate Axon Branching by the Cyclic GMP Pathway via Inhibition of Glycogen Synthase Kinase 3 in Dorsal Root Ganglion Sensory Neurons
Zhen Zhao,1,2
Zheng Wang,1
Ying Gu,1
Robert Feil,3
Franz Hofmann,3 and
Le Ma1,2
1Zilkha Neurogenetic Institute, Department of Cell and Neurobiology, Keck School of Medicine, and 2Neuroscience Graduate Program, University of Southern California, Los Angeles, California 90089, and 3Institut für Pharmakologie und Toxikologie, Technische Universität, D-80802 Munich, Germany
Correspondence should be addressed to Le Ma, Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, 1510 San Pablo Street, Los Angeles, CA 90089. Email: le.ma{at}usc.edu
Cyclic GMP has been proposed to regulate axonal development, but the molecular and cellular mechanisms underlying the formation of axon branches are not well understood. Here, we report the use of rodent embryonic sensory neurons from the dorsal root ganglion (DRG) to demonstrate the role of cGMP signaling in axon branching and to identify the downstream molecular pathway mediating this novel regulation. Pharmacologically, a specific cGMP analog promotes DRG axon branching in culture, and this activity can be achieved by activating the endogenous soluble guanylyl cyclase that produces cGMP. At the molecular level, the cGMP-dependent protein kinase 1 (PrkG1) mediates this activity, as DRG neurons isolated from the kinase-deficient mouse fail to respond to cGMP activation to make branches, whereas overexpression of a PrkG1 mutant with a higher-than-normal basal kinase activity is sufficient to induce branching. In addition, cGMP activation in DRG neurons leads to phosphorylation of glycogen synthase kinase 3 (GSK3), a protein that normally suppresses branching. This interaction is direct, because PrkG1 binds GSK3 in heterologous cells and the purified kinase can phosphorylate GSK3 in vitro. More importantly, overexpression of a dominant active form of GSK3 suppresses cGMP-dependent branching in DRG neurons. Thus, our study establishes an intrinsic signaling cascade that links cGMP activation to GSK3 inhibition in controlling axon branching during sensory axon development.
Key words: axon branching; cGMP; PrkG1; GSK3; bifurcation; sensory neuron
Received Aug. 5, 2008;
revised Nov. 26, 2008;
accepted Dec. 24, 2008.
Correspondence should be addressed to Le Ma, Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, 1510 San Pablo Street, Los Angeles, CA 90089. Email: le.ma{at}usc.edu
This article has been cited by other articles:

|
 |

|
 |
 
A. Tedeschi, T. Nguyen, S. U. Steele, S. Feil, U. Naumann, R. Feil, and S. Di Giovanni
The Tumor Suppressor p53 Transcriptionally Regulates cGKI Expression during Neuronal Maturation and Is Required for cGMP-Dependent Growth Cone Collapse
J. Neurosci.,
December 2, 2009;
29(48):
15155 - 15160.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Zhao and L. Ma
Regulation of axonal development by natriuretic peptide hormones
PNAS,
October 20, 2009;
106(42):
18016 - 18021.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Schmidt, A. Stonkute, R. Juttner, D. Koesling, A. Friebe, and F. G. Rathjen
C-type natriuretic peptide (CNP) is a bifurcation factor for sensory neurons
PNAS,
September 29, 2009;
106(39):
16847 - 16852.
[Abstract]
[Full Text]
[PDF]
|
 |
|